OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Hematology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis	71
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia	49
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis	47
Hormetic endoplasmic reticulum stress in hematopoietic stem cells	24
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies	23
Deficits in our understanding of natural killer cell development in mouse and human	21
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective	20
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function	19
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy	17
Mechanisms of immunothrombosis in COVID-19	17
Disparities in acute myeloid leukemia treatments and outcomes	16
Mesenchymal stromal cells: an update	16
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis	16
Developmental regulation of primitive erythropoiesis	16
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications	15
Platelet lifespan and mechanisms for clearance	15
The impact of obesity-induced inflammation on clonal hematopoiesis	14
Congenital neutropenia: disease models guiding new treatment strategies	13
Unraveling lipid metabolism for acute myeloid leukemia therapy	12
The new world: hematopoietic stem cell transplant during a pandemic	12
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation	12
Editorial introductions	11
High-throughput genotyping tools for red blood cell antigens	11
Editorial introductions	11
Advances on the genetic basis of red cell membrane disorders	10

Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia	10
Humanized murine models of platelet function	10
Multifaceted roles of CRISPR technology in blood cancer research	9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration	9
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential	9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation	8
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies	8
Editorial introduction	8
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers	7
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms	7
Understanding and targeting erythroid progenitor cells for effective cancer therapy	7
Red cells: not only hemoglobin – plasma membranes are also of paramount importance	7
Editorial introductions	7
Editorial introductions	7
Platelets in vascular inflammation: fire-fighters or pyromaniacs?	7
Red blood cell changes due to cancer and cancer treatments: a narrative review	7
Chediak-Higashi syndrome	6
Current Opinion in Hematology	6
Modelling arterial thrombus formation in vitro	6
Venous thromboembolism: diagnostic advances and unaddressed challenges in management	6
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells	6
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods	6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology	6
The immunology of PF4 polyanion interactions	6
Models to study myelodysplastic syndrome and acute myeloid leukaemia	5
PROTACs in platelets: emerging antithrombotic strategies and future perspectives	5
The state of prediction models in hematologic disease: a worrisome assessment	5
Translation defects in ribosomopathies	5
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease	5
Platelet transfusion	5